Serum alarmin S100A8/S100A9 levels and its potential role as biomarker in myocarditis

Serum alarmin S100A8/S100A9 levels and its potential role as biomarker in myocarditis

Abstract Aims The alarmin S100A8/S100A9 (S100A8/A9) is released by activated monocytes/macrophages and neutrophils in the setting lymphocytic myocarditis (MC). We recently demonstrated its therapeutic potential in experimental acute MC. Now, we investigated the diagnostic relevance of S100A8/A9 seru...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Irene Müller, Thomas Vogl, Uwe Kühl, Alexander Krannich, Aron Banks, Tobias Trippel, Michel Noutsias, Alan S. Maisel, Sophie vanLinthout, Carsten Tschöpe
Materialtyp: Artikel
Språk:English
Publicerad: Wiley 2020-08-01
Serie:ESC Heart Failure
Ämnen:
S100A8/S100A9
Myocarditis
Endomyocardial biopsy
Länkar:https://doi.org/10.1002/ehf2.12760

Internet

https://doi.org/10.1002/ehf2.12760

Liknande verk